» Authors » Eric M Veys

Eric M Veys

Explore the profile of Eric M Veys including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 1168
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vandooren B, Melis L, Veys E, Tak P, Baeten D
Arthritis Rheum . 2009 Apr; 60(4):1020-5. PMID: 19333923
Objective: In vitro spontaneous osteoclastogenesis from peripheral blood mononuclear cells (PBMCs) is increased in diseases with excessive bone loss. The purpose of this study was to reassess the role of...
2.
Kruithof E, Van den Bossche V, De Rycke L, Vandooren B, Joos R, Canete J, et al.
Arthritis Rheum . 2006 Jul; 54(8):2594-604. PMID: 16868982
Objective: To characterize the synovial immunopathologic features of juvenile-onset spondylarthritis (SpA) in relation to adult SpA and other forms of juvenile idiopathic arthritis (JIA). Methods: Synovial biopsy samples were obtained...
3.
Kruithof E, De Rycke L, Vandooren B, De Keyser F, FitzGerald O, McInnes I, et al.
Arthritis Rheum . 2006 May; 54(6):1795-804. PMID: 16729282
Objective: To identify biomarkers for effective treatment in early-phase clinical trials of spondylarthritis (SpA), by analyzing which synovial features can be reliably identified in patients with SpA. Methods: Synovial biopsies...
4.
Verdonk P, Demurie A, Almqvist K, Veys E, Verbruggen G, Verdonk R
J Bone Joint Surg Am . 2006 Mar; 88 Suppl 1 Pt 1:109-18. PMID: 16510805
Background: Few medium-term or long-term reports on meniscal allograft transplantations are available. In this study, we present the results of a survival analysis of the clinical outcomes of our first...
5.
Verdonk P, Verstraete K, Almqvist K, De Cuyper K, Veys E, Verbruggen G, et al.
Knee Surg Sports Traumatol Arthrosc . 2006 Feb; 14(8):694-706. PMID: 16463170
Long-term data on the clinical outcome and the fate of the meniscus allograft after transplantation are scarce. In this study we present the clinical, radiological and MRI outcome of the...
6.
Kruithof E, De Rycke L, Roth J, Mielants H, Van den Bosch F, De Keyser F, et al.
Arthritis Rheum . 2005 Dec; 52(12):3898-909. PMID: 16329106
Objective: Because different tumor necrosis factor alpha (TNFalpha) blockers may have distinct immunomodulatory effects on specific disease manifestations, the present study was carried out to investigate the immunomodulating effects of...
7.
Vranken E, Versijpt J, Winne L, Veys E, Hamphrey H
Clin Nucl Med . 2005 Oct; 30(11):740-1. PMID: 16237300
No abstract available.
8.
Vander Cruyssen B, Van Looy S, Wyns B, Westhovens R, Durez P, Van den Bosch F, et al.
Arthritis Res Ther . 2005 Oct; 7(5):R1063-71. PMID: 16207323
This study is based on an expanded access program in which 511 patients suffering from active refractory rheumatoid arthritis (RA) were treated with intravenous infusions of infliximab (3 mg/kg+methotrexate (MTX))...
9.
De Rycke L, Nicholas A, Cantaert T, Kruithof E, Echols J, Vandekerckhove B, et al.
Arthritis Rheum . 2005 Jul; 52(8):2323-30. PMID: 16052592
Objective: To address the ongoing debate concerning the specificity of synovial citrullinated proteins for rheumatoid arthritis (RA) and to analyze their pathophysiologic relevance to the induction or perpetuation of the...
10.
De Rycke L, Vandooren B, Kruithof E, De Keyser F, Veys E, Baeten D
Arthritis Rheum . 2005 Jun; 52(7):2146-58. PMID: 15986373
Objective: Abnormal host defense against pathogens has been implicated in the pathogenesis of spondylarthropathy (SpA), a disease characterized by abundant synovial infiltration with innate immune cells. Given the role of...